selenomethionine
Sponsors
Roswell Park Cancer Institute, Milton S. Hershey Medical Center, University of Siena, University of Auckland, New Zealand
Conditions
Chemotherapeutic Agent ToxicityColorectal AdenomaColorectal CancerEffect of Selenium on Oxidative Stress in Healthy MenLung CancerMucositisProstate CancerRadiation Toxicity
Phase 1
Phase 2
Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
TerminatedNCT00526890
Start: 2006-10-31End: 2010-09-30Updated: 2017-11-28
Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma
TerminatedNCT00625183
Start: 2008-03-31End: 2009-12-31Updated: 2017-11-17
Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate Cancer
WithdrawnNCT00736164
Start: 2008-08-31Updated: 2012-02-06
Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
CompletedNCT00736645
Start: 2008-08-31End: 2012-12-31Updated: 2023-10-02
Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy
TerminatedNCT01682031
Start: 2009-06-30End: 2012-06-30Updated: 2014-08-22
Effect of Semet (80 and 160 mcg) Versus Placebo in Euthyroid Patients With AIT
NCT02302768
Start: 2012-12-31End: 2015-01-31Updated: 2014-11-27